Who
Richard Kuntz
Director
Company insider
Files Form 4 as: Director, INVE Technologies; Director, DiaMedica Therapeutics; Director, ZimVie; Director, Rockley Photonics Holdings; SVP & Chief Medical & Science, Medtronic plc; SrVP & Chief Scien, Clin, Reg, Medtronic; Director, Tengion.
In numbers
- Trades disclosed
- 193
- Buys
- 2
- Sells
- 16
- Bought
- $7.0M
- Sold
- $36.5M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 31 Jul 2006
- Last trade
- 30 Jul 2026
- Last filed
- 3 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jul 2026filed 3 Aug 2026 | INVE INVE TechnologiesHardware, Devices & Storage | SEC FORM 4 Code A | —17,544 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | INVE INVE TechnologiesHardware, Devices & Storage | SEC FORM 4 Code A | —17,544 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,412 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,412 at $0.00 | filing |
| 20 Oct 2025filed 20 Oct 2025 | ZimVieoption or derivative | SEC FORM 4 Code D | —13,072.97 | filing |
| 20 Oct 2025filed 20 Oct 2025 | ZimVieoption or derivative | SEC FORM 4 Code D | —57,728 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —662.31 at $0.00 | filing |
| 29 Jul 2025filed 31 Jul 2025 | INVE INVE TechnologiesHardware, Devices & Storage | SEC FORM 4 Code A | —21,148 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —1,340.91 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,162 at $0.00 | filing |
| 7 May 2025filed 9 May 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 7 May 2025filed 9 May 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —21,119 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —1,163.03 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Code A | $53K9,925 at $5.34 | filing |
| 31 Dec 2024filed 3 Jan 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —894.9 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —795.02 at $0.00 | filing |
| 29 Jul 2024filed 23 Oct 2024 | INVE INVE TechnologiesHardware, Devices & Storage | SEC FORM 4 Code A | —14,773 at $0.00 | filing |
| 30 Jun 2024filed 2 Jul 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —696.92 at $0.00 | filing |
| 1 Jun 2024filed 3 Jun 2024 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,472 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —500 at $0.00 | filing |
News
8th Circ. Panel Doubts Investors' Medtronic Insulin Pump SuitMDT · law360.com · 21 Oct 2026Medtronic: How an Olympic Runner Found Relief From Fecal IncontinenceMDT · finanznachrichten.de · 19 Oct 2026Medtronic Completes MiniMed Separation After Oversubscribed ExchangeMDT · finchannel.com · 18 Oct 2026
0 headlines in the last 90 days name Richard Kuntz; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.